---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-209988"
form_type: "8-K"
ticker: "TPST"
cik: "0001544227"
company_name: "Tempest Therapeutics, Inc."
filed_at: "2021-07-07T23:59:59+00:00"
generated_at: "2026-06-30T06:55:24.443100+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Tempest Therapeutics appoints Christine Pellizzari to board, enters new exec employment agreements

## Summary
- Appointed Christine Pellizzari as Class II Director, serving on Audit Committee; term expires 2023.
- CEO Stephen Brady gets $475,283 base salary, 40% target bonus, 250k stock options, and severance of 12–18 months salary plus bonus.
- President Thomas Dubensky gets $476,283 base, 40% target bonus, 250k options; severance of 12–18 months salary plus bonus.
- CMO Samuel Whiting gets $400k base, 35% target bonus; severance of 9–12 months salary plus bonus.
- All directors and executive officers entered indemnification agreements with the Company.

## SEC filing metadata
- accession: 0001193125-21-209988
- form_type: 8-K
- ticker: TPST
- cik: 0001544227
- company_name: Tempest Therapeutics, Inc.
- filed_at: 2021-07-07T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1544227/000119312521209988/0001193125-21-209988-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1544227/000119312521209988/d69289d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-209988
- JSON: https://secwatch.observer/filing/0001193125-21-209988.json
- Plain text: https://secwatch.observer/filing/0001193125-21-209988.txt

## Key facts
- Executive change
  Christine Pellizzari was appointed as Class II Director at Tempest Therapeutics, Inc..
  - Action: appointed
  - Role: Class II Director
  source text: On July 1, 2021, the Board appointed Christine Pellizzari as a Class II Director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1544227/000119312521209988/0001193125-21-209988-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.